Sign up to save your podcasts
Or
Share The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
Host: Naim Alkhouri, MD, FAASLD, DABOM
MASLD/MASH is a serious, chronic, progressive disease that will soon be the most common indication for liver transplantation and a major driver of the development of liver cancer. Do you know how to effectively treat MASLD/MASH in your patients, and are you familiar with drugs currently in development? Tune in for an overview of the latest data.
View all episodes
By ReachMDHost: Naim Alkhouri, MD, FAASLD, DABOM
MASLD/MASH is a serious, chronic, progressive disease that will soon be the most common indication for liver transplantation and a major driver of the development of liver cancer. Do you know how to effectively treat MASLD/MASH in your patients, and are you familiar with drugs currently in development? Tune in for an overview of the latest data.